• Return to Headlines

Downtrend Call Working As Impax Laboratories Stock Falls 19.7% (IPXL)

By James Quinn

SmarTrend identified a Downtrend for Impax Laboratories (NASDAQ:IPXL) on October 26th, 2012 at $24.54. In approximately 4 months, Impax Laboratories has returned 19.71% as of today's recent price of $19.70.

Over the past year, Impax Laboratories has traded in a range of $14.46 to $28.75 and is now at $19.70, 36% above that low. The 200-day and 50-day moving averages have moved 0.24% lower and 0.33% lower over the past week, respectively.

Impax Laboratories, Inc. develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. The Company specializes in the development of niche and controlled release generics, as well as the development of branded products.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Impax Laboratories.

Log in and add Impax Laboratories (IPXL) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights impax laboratories

Ticker(s): IPXL